Personal tools

Coexpression cluster:C2645: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|gostat_on_coexpression_clusters=GO:0030031!cell projection biogenesis!0.0432709290003532!5880$GO:0042330!taxis!0.0432709290003532!5880$GO:0006935!chemotaxis!0.0432709290003532!5880$GO:0007626!locomotory behavior!0.0432709290003532!5880$GO:0005635!nuclear envelope!0.0432709290003532!5880$GO:0032990!cell part morphogenesis!0.0432709290003532!5880$GO:0048858!cell projection morphogenesis!0.0432709290003532!5880$GO:0030030!cell projection organization and biogenesis!0.0432709290003532!5880$GO:0008284!positive regulation of cell proliferation!0.0432709290003532!5880$GO:0030036!actin cytoskeleton organization and biogenesis!0.0432709290003532!5880$GO:0030029!actin filament-based process!0.0432709290003532!5880$GO:0003924!GTPase activity!0.0432709290003532!5880$GO:0007610!behavior!0.0432709290003532!5880
|gostat_on_coexpression_clusters=GO:0030031!cell projection biogenesis!0.0432709290003532!5880$GO:0042330!taxis!0.0432709290003532!5880$GO:0006935!chemotaxis!0.0432709290003532!5880$GO:0007626!locomotory behavior!0.0432709290003532!5880$GO:0005635!nuclear envelope!0.0432709290003532!5880$GO:0032990!cell part morphogenesis!0.0432709290003532!5880$GO:0048858!cell projection morphogenesis!0.0432709290003532!5880$GO:0030030!cell projection organization and biogenesis!0.0432709290003532!5880$GO:0008284!positive regulation of cell proliferation!0.0432709290003532!5880$GO:0030036!actin cytoskeleton organization and biogenesis!0.0432709290003532!5880$GO:0030029!actin filament-based process!0.0432709290003532!5880$GO:0003924!GTPase activity!0.0432709290003532!5880$GO:0007610!behavior!0.0432709290003532!5880
|id=C2645
|id=C2645
|ontology_enrichment_celltype=CL:0000037!1.01e-46!172;CL:0000566!1.01e-46!172;CL:0000988!5.94e-45!182;CL:0002032!2.71e-44!165;CL:0000837!2.71e-44!165;CL:0000738!2.87e-41!140;CL:0002087!2.85e-38!119;CL:0002031!2.93e-38!124;CL:0000763!1.70e-23!112;CL:0000049!1.70e-23!112;CL:0000766!4.31e-22!76;CL:0000839!8.94e-20!70;CL:0000542!1.96e-19!53;CL:0000051!1.96e-19!53;CL:0000838!2.50e-19!52;CL:0002057!2.67e-18!42;CL:0000723!3.70e-18!436;CL:0000557!4.08e-18!71;CL:0000048!4.83e-18!430;CL:0000034!2.52e-17!444;CL:0002194!3.10e-17!63;CL:0000576!3.10e-17!63;CL:0000040!3.10e-17!63;CL:0000559!3.10e-17!63;CL:0002320!3.26e-16!365;CL:0000134!3.97e-16!358;CL:0002009!5.70e-16!65;CL:0002371!6.74e-16!591;CL:0000860!3.35e-15!45;CL:0000003!2.56e-14!722;CL:0000144!6.86e-13!625;CL:0000084!8.05e-12!25;CL:0000827!8.05e-12!25;CL:0000791!1.19e-09!18;CL:0000789!1.19e-09!18;CL:0002420!1.19e-09!18;CL:0002419!1.19e-09!18;CL:0000790!1.19e-09!18;CL:0000219!7.62e-09!390;CL:0000063!1.22e-08!578;CL:0000945!6.60e-08!24;CL:0000826!6.60e-08!24;CL:0000012!4.84e-07!682
|ontology_enrichment_disease=DOID:2531!1.58e-09!51;DOID:0060083!1.58e-09!51;DOID:1240!5.88e-08!39
|ontology_enrichment_uberon=UBERON:0002193!5.07e-25!112;UBERON:0003081!1.09e-23!216;UBERON:0002390!7.68e-23!102;UBERON:0003061!7.68e-23!102;UBERON:0002371!2.40e-16!80;UBERON:0002405!3.13e-15!115;UBERON:0002384!8.75e-15!375;UBERON:0001474!1.20e-12!86;UBERON:0004765!3.81e-10!101;UBERON:0001434!3.81e-10!101;UBERON:0004535!3.27e-09!110;UBERON:0000055!3.84e-09!69;UBERON:0002204!1.10e-08!167;UBERON:0001009!2.19e-08!113;UBERON:0001981!1.38e-07!60;UBERON:0007500!1.38e-07!60;UBERON:0004537!1.38e-07!60;UBERON:0006965!1.38e-07!60;UBERON:0001637!1.64e-07!42;UBERON:0003509!1.64e-07!42;UBERON:0004572!1.64e-07!42;UBERON:0004872!5.41e-07!84
}}
}}

Revision as of 14:26, 21 May 2012


Full id: C2645_Neutrophils_Mast_CD4_Whole_chronic_Monocytederived_meningioma



Phase1 CAGE Peaks

Hg19::chr22:37621736..37621790,-p7@RAC2
Hg19::chr22:37628003..37628037,-p9@RAC2
Hg19::chr22:37628892..37628908,-p@chr22:37628892..37628908
-
Hg19::chr22:37637680..37637701,-p1@M64595


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0030031cell projection biogenesis0.0432709290003532
GO:0042330taxis0.0432709290003532
GO:0006935chemotaxis0.0432709290003532
GO:0007626locomotory behavior0.0432709290003532
GO:0005635nuclear envelope0.0432709290003532
GO:0032990cell part morphogenesis0.0432709290003532
GO:0048858cell projection morphogenesis0.0432709290003532
GO:0030030cell projection organization and biogenesis0.0432709290003532
GO:0008284positive regulation of cell proliferation0.0432709290003532
GO:0030036actin cytoskeleton organization and biogenesis0.0432709290003532
GO:0030029actin filament-based process0.0432709290003532
GO:0003924GTPase activity0.0432709290003532
GO:0007610behavior0.0432709290003532



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen
hematopoietic stem cell1.01e-46172
angioblastic mesenchymal cell1.01e-46172
hematopoietic cell5.94e-45182
hematopoietic oligopotent progenitor cell2.71e-44165
hematopoietic multipotent progenitor cell2.71e-44165
leukocyte2.87e-41140
nongranular leukocyte2.85e-38119
hematopoietic lineage restricted progenitor cell2.93e-38124
myeloid cell1.70e-23112
common myeloid progenitor1.70e-23112
myeloid leukocyte4.31e-2276
myeloid lineage restricted progenitor cell8.94e-2070
lymphocyte1.96e-1953
common lymphoid progenitor1.96e-1953
lymphoid lineage restricted progenitor cell2.50e-1952
CD14-positive, CD16-negative classical monocyte2.67e-1842
somatic stem cell3.70e-18436
granulocyte monocyte progenitor cell4.08e-1871
multi fate stem cell4.83e-18430
stem cell2.52e-17444
monopoietic cell3.10e-1763
monocyte3.10e-1763
monoblast3.10e-1763
promonocyte3.10e-1763
connective tissue cell3.26e-16365
mesenchymal cell3.97e-16358
macrophage dendritic cell progenitor5.70e-1665
somatic cell6.74e-16591
classical monocyte3.35e-1545
native cell2.56e-14722
T cell8.05e-1225
pro-T cell8.05e-1225
mature alpha-beta T cell1.19e-0918
alpha-beta T cell1.19e-0918
immature T cell1.19e-0918
mature T cell1.19e-0918
immature alpha-beta T cell1.19e-0918
motile cell7.62e-09390
lymphocyte of B lineage6.60e-0824
pro-B cell6.60e-0824
Uber Anatomy
Ontology termp-valuen
hemolymphoid system5.07e-25112
lateral plate mesoderm1.09e-23216
hematopoietic system7.68e-23102
blood island7.68e-23102
bone marrow2.40e-1680
immune system3.13e-15115
connective tissue8.75e-15375
bone element1.20e-1286
skeletal element3.81e-10101
skeletal system3.81e-10101
cardiovascular system3.27e-09110
vessel3.84e-0969
musculoskeletal system1.10e-08167
circulatory system2.19e-08113
blood vessel1.38e-0760
epithelial tube open at both ends1.38e-0760
blood vasculature1.38e-0760
vascular cord1.38e-0760
artery1.64e-0742
arterial blood vessel1.64e-0742
arterial system1.64e-0742
splanchnic layer of lateral plate mesoderm5.41e-0784
Disease
Ontology termp-valuen
hematologic cancer1.58e-0951
immune system cancer1.58e-0951
leukemia5.88e-0839


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.